{
  "@context": "https://exchange.beregov.me/api/json/ld/v1/context.jsonld",
  "@id": "https://exchange.beregov.me/api/v1/exchange/catalog/venues/bybit/tradfi/lly",
  "@type": "Instrument",
  "id": "venues/bybit/tradfi/lly",
  "name": {
    "en": "Eli Lilly",
    "ru": "Eli Lilly"
  },
  "url": "https://exchange.beregov.me/catalog/venues/bybit/tradfi/lly/",
  "description": {
    "en": "LLY · Последнее: Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug",
    "ru": "LLY · Последнее: Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug"
  },
  "items": [
    {
      "@id": "https://exchange.beregov.me/api/v1/exchange/news/2026/11/13/eli-lilly-beats-novo-nordisk-to-china-approval-for-first-oral-glp-1-weight-loss",
      "id": "t:eli lilly beats novo nordisk to china approval for first oral glp 1 weight loss drug",
      "name": {
        "en": "Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug",
        "ru": "Eli Lilly beats Novo Nordisk to China approval for first oral GLP-1 weight-loss drug"
      },
      "url": "https://exchange.beregov.me/news/2026/11/13/eli-lilly-beats-novo-nordisk-to-china-approval-for-first-oral-glp-1-weight-loss/",
      "date": "2026-11-13"
    }
  ],
  "parent": "https://exchange.beregov.me/api/v1/exchange/catalog/venues/bybit/tradfi",
  "dimension": "venues",
  "value": "bybit/tradfi/lly"
}